Mitsubishi
8058
Mitsubishi UFJ Financial Group
8306
Metaplanet
3350
4
ITOCHU
8001
5
Marubeni
8002
JP Stock MarketDetailed Quotes
4888 Stella Pharma
- 328
- +1+0.31%
20min DelayMarket Closed May 2 15:30 JST
11.16BMarket Cap-13.30P/E (Static)
331High325Low107.70KVolume329Open327Pre Close35.32MTurnover60252wk High0.54%Turnover Ratio34.03MShares28152wk Low-22.92EPS TTM6.53BFloat Cap1070Historical HighLossP/E (Static)19.91MShs Float229Historical Low-24.66EPS LYR1.84%Amplitude--Dividend TTM3.62P/B100Lot Size--Div YieldTTM
About Stella Pharma Company
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.
Company Profile
Symbol4888
Company NameStella Pharma
Founded2007-06-01
MarketTSE Growth
Fiscal Year Ends03-31
Address3-2-7 Korai-bashi Chuo-ku, Osaka Prefecture
Zip Code541-0043
Phone06-4707-1516
Websitewww.stella-pharma.co.jp
Company Executives
- Name
- Position
- Salary
- Koki Uehara
- Representative Director and President
- --
- Wako Yabu
- Director
- --
- Toshimitsu Hayashi
- Director
- --
- Takahiro Kido
- Director
- --
- Takashi Fukuchi
- Independent Director
- --
- Masaya Oonishi
- Independent Director
- --
- Kohei Tsujii
- Independent Director
- --